Extracts from Aloe ferox and Withania somnifera inhibit Candida albicans and Neisseria gonorrhoea by Kambiz, L & Afolayan, AJ
African Journal of Biotechnology Vol. 7 (1), pp. 012-015, 4 January, 2008     
Available online at http://www.academicjournals.org/AJB 





Full Length Research Paper 
 
Extracts from Aloe ferox and Withania somnifera inhibit 
Candida albicans and Neisseria gonorrhoea 
 
L. Kambizi1* and A.J. Afolayan2 
 
1Walter Sisulu University, Biological Sciences Department, P. Bag X1 Mthatha 5117, South Africa. 
2Fort Hare University, Botany Department, Alice 5700, South Africa. 
 
Accepted 14 November, 2007 
 
Herbal medicines play a vital role in the treatment of sexually transmitted infections (STIs), especially in 
the remote areas of South Africa where clinics and hospitals are sparsely located. Aloe ferox and 
Withania somnifera are among the southern African plants commonly used for the treatment of (STIs). 
This paper reports on the in vitro antimicrobial activities of water and methanol extracts from the two 
plants on Neisseria gonorrhoea and Candida albicans, common causes of STIs in rural South Africa. 
Extracts from both species together with pure aloin from A. ferox, were evaluated for activity against six 
strains of N. gonorrhoea and nine strains of C. albicans. The extracts showed activity against N. 
gonorrhoea at concentrations of ranging from 0.5 (methanol extracts from both) to 10 (water extract of 
W. somnifera only) mg/ml while pure aloin inhibited the growth of both microorganisms. Only the 
methanol extract of W. somnifera was effective against C. albicans at a concentration of 20 mg/ml.  
 





The indigenous people of the Eastern Cape Province in 
South Africa have a long history of traditional plant usage 
for the treatment of various diseases and ailments (Van 
Wyk et al., 1997; Grierson and Afolayan, 1999) including 
sexually transmitted infections (STIs). In the remote rural 
communities of the province, STIs are common among 
young adults and herbalists take advantage of the bio-
diversity of plant species to treat these infections.  
The commonest and most frequently reported STIs in 
the Eastern Cape province of South Africa, apart from the 
HIV and AIDS, are gonorrhoea, herpes and syphilis 
(Kambizi and Afolayan, 2003). These diseases are caus-
ed by bacteria and viruses. The commonest disease is 
gonorrhoea which is caused by Neisseria gonorrhoea, a 
Gram-negative bacterium. It was discovered in 1879 by 
Neisser (Kelly, 1992). The organism attacks mucous 
membranes, especially the columnar epithelium found in 
the urethra, the cervix uteri, rectum and conjunctivae. An 
intense inflammatory reaction follows with a massive 
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the mucosal lining by N. gonorrhoea (Daly et al., 1994; 
Mariam et al., 2004). The incubation period is 2 - 5 days. 
In men the main symptom of the disease is a profuse 
purulent urethral discharge while it is asymptomatic in 
women. The microorganism causes some complications 
in men such as epididymitis and prostatitis while in 
women the most important complication is pelvic inflam-
matory disease (Fenton and Lowndes, 2004; Mariam et 
al., 2004). 
Candidiasis is one of the diseases treated by herbalists 
in the Eastern Cape. It is caused by a dimorphic fungus 
called Candida albicans. This fungus exists as oval, 
single yeast cells, which reproduce by budding (de 
Repentigny, 2004). Although C. albicans most frequently 
infects the skin and mucosal surfaces, it can cause 
systemic infections manifesting as pneumonia, septicae-
mia or endocarditis in severely immunocompromised 
patients. According to Lamb et al., (2000), it grows 
vigorously in the vagina and pregnant women transmit 
the infection to the babies during birth. 
In a previous survey of plants used for the treatment of 
STIs (Kambizi and Afolayan, 2003), traditional healers 
and other knowledgeable rural dwellers of the Eastern 
Cape listed Aloe ferox (Family Asphodelaceae) and 





commonest plant species used for the treatment of 
gonorrhoea and candidiasis. A. ferox is widely used in 
traditional medicine. According to many authors, the 
species is used as an anti-inflammatory and anticancer 
agent such as in the treatment of leukemia and against 
neuroectodermal tumors (Van Wyk et al., 1997; Capasso 
et al., 1998; Pecere, 2000). Withania somnifera grows 
widely in the Eastern Cape and is used for the treatment 
of arthritis, tuberculosis, cancer and STIs (Devi, 1996; 
Van Wyk et al., 1997; Singh and Kumar, 1998). 
The antimicrobial properties of these two plant species 
have been widely reported in literatures (Afolayan et al., 
2002; Arora et al., 2004). However, the reports have 
focused mainly on their activities against commensal 
microbial flora while information on their activity against 
human pathogens is scanty. In this study, we examined 
the antimicrobial activities of the aqueous extracts from 




MATERIALS AND METHOD 
 
Plant collection  
 
The leaves of A. ferox and the roots of W. somnifera were collected 
from villages around Alice in the Eastern Cape. According to the 
traditional healers in the study area, only the roots of W. somnifera 
are used for the treatment of STIs. Voucher specimens (Kambizi 
Med.2003/1 and Kambizi Med.2003/2) were prepared, properly 
identified and deposited at the University of Fort Hare Botany 
Department (Kambizi and Afolayan 2003).   
 
 
Preparation of the extracts 
 
Air-dried plant materials (leaves of A. ferox and the roots of W. 
somnifera) (50 g each) were pulverised and shaken for 30 min in 
300 ml of water and 300ml of methanol respectively (Afolayan and 
Meyer 1997). The extracts were filtered through Whatman No.1 
filter paper and concentrated to dryness under reduced pressure. 
Each dry extract was later redissolved in its respective solvent, 
either water or methanol to final concentrations of 0.1, 5.0, 10 and 
20 mg/ml (Taylor et al., 1996). Stock solutions (0.1 and 5 mg/ml) of 
pure aloin, which was previously isolated from A. ferox (Kambizi et 





Six clinical isolates of N. gonorrhea were procured from the STI unit 
of the National Health Laboratory Service in Johannesburg. They 
were maintained on New York City agar in the laboratory. Nine 
laboratory strains of C. albicans were cultured and maintained on 





Sensitivity testing of the two microorganisms to the water and 
methanol extracts of the plants was carried out on Potato Dextrose 
agar. 5 ml of the agar was sterilised at 121°C for 20 min in the 
autoclave and then mixed with the different extracts to make final 
concentrations of 0.5, 1.0, 5.0, 10 and 20 mg of extract ml-1 of agar. 
The agar-extract mixture was then poured into 65 mm  Petri  dishes  




and was allowed to cool and set. All extracts were also plated out 
on normal Blood agar plates to ensure sterility. The minimum 
inhibitory concentration (MIC) value was considered as the lowest 
extract concentration with no visible growth. Blank plates containing 






N. gonorrhoea was cultured anaerobically in Mueller-Hinton broth 
(Merck, Darmstadt, Germany) at 37°C for 48 h based on the 
National Committee for Clinical Laboratory Standards (NCCLS) 
(1997) protocols. The strains were multipoint-inoculated using a 
MacFarland standard into 5 ml of Mueller-Hinton broth at 37°C. The 
extract plates were inoculated with 6 strains of N. gonorrhoea and 
were incubated in anaerobic conditions at 37°C. All extracts were 
plated out on normal Blood Agar plates to ensure sterility. Minimum 
inhibitory concentrations (MIC) of the compounds were determined 
after 48 h of incubation. The MIC value was considered as the 





Strains of C. albicans were cultured and maintained on Sabourard 
Dextrose Agar. Pure colonies of C. albicans were inoculated onto 
the prepared extract plates using McFarland standard and incuba-
ted for 72 h at 37°C. 
 
 
RESULTS AND DISCUSSION 
 
Water extracts from A. ferox did not show any activity 
against N. gonorrhoea. The organism is a Gram-negative 
bacterium which belongs to a group of microbes that 
have been reported to be more resistant to plant extracts 
than the Gram-positive organisms (Geyid, 2002). Similar 
observations were noted by Afolayan et al. (2002) who 
reported that a pure compound (3,5,7-trihydroxyflavone) 
isolated from the shoots of Helichrysum aureonitens was 
not active on the following Gram-negative bacteria: 
Escherichia coli, Klebsiella pneumoniae, Pseudomonas 
aeruginosa and Serratia marcescens. Kambizi and 
Afolayan (2003) also observed that water; methanol and 
acetone extracts did not show activity on S. marcescens, 
a gram-negative bacterium. Water extracts from W 
somnifera, however, exhibited complete inhibition of N. 
gonorrhoea at 10 mg/ml. The ability of water extract from 
this plant to inhibit the growth of N. gonorrhoea may be 
the reason for its use by the herbalists for the treatment 
of gonorrhoea. Methanol extracts from A. ferox and W. 
somnifera exhibited activity against all the strains of N. 
gonorrhoea at a concentration of 0.5 mg/ml. However, 
aloin (a pure compound isolated from A. ferox) inhibited 
the bacteria at a much lower concentration of 0.1 mg/ml 
(Table 1). However, cytotoxicity studies (Kambizi et al., 
2007) on aloin have shown that at a concentration of 0.1 
mg/ml, the compound does not exhibit any toxic effects in 
cell culture. Previous work (Kambizi et al., 2004) have 
shown that other compounds such as aloe emodin and 
chrysophanol present in the extracts of A. ferox  are  also 












Table 2. Inhibitory effects of aqueous extracts from A. ferox and W. somnifera on C. albicans. 
 
Minimum inhibitory concentration (mg/ml) 
A. ferox W. somnifera 
 
C. albicans  
strains Water Methanol Aloin Water Methanol 
1 C na na 5.0 na 20.0 
2 C na na 5.0 na 20.0 
3 C na na 5.0 na 20.0 
4 C na na 5.0 na 20.0 
5 C na na 5.0 na 20.0 
6 C na na 5.0 na 20.0 
7 C na na 5.0 na 20.0 
8 C na na 5.0 na 20.0 
9 C na na 5.0 na 20.0 
 




responsible for the antimicrobial activity exhibited. 
The antifungal screening showed that aloin was active 
against all strains of C. albicans at a concentration of 5 
mg/ml. Water extracts from both plants did not show any 
activity against C. albicans. Methanol extract from A. 
ferox exhibited low activity at a concentration of 20 mg/ml 
(Table 2). Some researchers (Vahidi et al., 2002; Bonjar 
2004, Iwalokun et al., 2004) have reported high 
resistance of C. albicans to plant extracts and hence 
recommended antifungal testing at concentrations as 
high as 100 mg/ml. The herbalists in the study area 
prescribe decoctions (water extracts) to their patients with 
no upper limit to their concentrations. This may suggest 
that the high concentration of the extracts administered to 
patients may be able to cure the disease.  
It was important to screen extracts from A. ferox and 
W. somnifera against C. albicans because many fungal 
infections have been reported to be the primary cause of 
mortality in patients with severely impaired host defence 
mechanisms (Kulberg, 1997). The increase of AIDS-
related fungal opportunistic pathogens and the emer-
gence of resistant strains in recent years have lent 
additional urgency to studies on potential antifungals. In 
the present study it is of interest to note the correlation 
between the claims of herbalists and the demonstrated 
antimicrobial activity of the extracts from W. somnifera on 
N. gonorrhoea. However, further studies are needed to 
determine whether the plants are effective against 
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